false
0001611747
2026-06-30
Q2
--12-31
P3Y
P3Y
P3Y
P3Y
P3Y
P3Y
P3Y
P3Y
P3Y
P3Y
0001611747
2026-01-01
2026-06-30
0001611747
srt:ScenarioForecastMember
2026-08-19
2026-08-19
0001611747
scni:ADSsMember
2026-08-19
2026-08-19
0001611747
srt:ScenarioForecastMember
us-gaap:CommonStockMember
2026-08-19
2026-08-19
0001611747
scni:ADSsMember
srt:ScenarioForecastMember
2026-08-20
2026-08-20
0001611747
srt:ScenarioForecastMember
2026-08-20
0001611747
srt:ScenarioForecastMember
2026-08-10
0001611747
srt:ScenarioForecastMember
2026-08-10
2026-08-10
0001611747
us-gaap:SubsequentEventMember
2026-07-01
2026-07-01
0001611747
us-gaap:SubsequentEventMember
2026-07-01
0001611747
2025-01-01
2025-06-30
0001611747
scni:ContractDevelopmentAndManufacturingOrganizationMember
2025-01-01
2025-06-30
0001611747
scni:OtherMember
2025-01-01
2025-06-30
0001611747
scni:CostOfRevenuesMember
2025-01-01
2025-06-30
0001611747
scni:ContractDevelopmentAndManufacturingOrganizationMember
scni:CostOfRevenuesMember
2025-01-01
2025-06-30
0001611747
scni:OtherMember
2026-01-01
2026-06-30
0001611747
scni:ContractDevelopmentAndManufacturingOrganizationMember
2026-01-01
2026-06-30
0001611747
scni:ExternalMember
2026-01-01
2026-06-30
0001611747
scni:OtherMember
scni:ExternalMember
2026-01-01
2026-06-30
0001611747
scni:ContractDevelopmentAndManufacturingOrganizationMember
scni:ExternalMember
2026-01-01
2026-06-30
0001611747
scni:OutsideIsraelMember
2025-01-01
2025-06-30
0001611747
scni:OutsideIsraelMember
2026-01-01
2026-06-30
0001611747
country:IL
2025-01-01
2025-06-30
0001611747
country:IL
2026-01-01
2026-06-30
0001611747
scni:ADSsMember
srt:ScenarioForecastMember
2026-08-19
2026-08-19
0001611747
scni:WarrantsMember
2025-01-01
2025-06-30
0001611747
scni:PreferredSharesMember
2025-01-01
2025-06-30
0001611747
us-gaap:RestrictedStockMember
2025-01-01
2025-06-30
0001611747
scni:ShareOptionMember
2025-01-01
2025-06-30
0001611747
scni:WarrantsMember
2026-01-01
2026-06-30
0001611747
scni:PreferredSharesMember
2026-01-01
2026-06-30
0001611747
us-gaap:RestrictedStockMember
2026-01-01
2026-06-30
0001611747
scni:ShareOptionMember
2026-01-01
2026-06-30
0001611747
2026-06-30
0001611747
us-gaap:RestrictedStockUnitsRSUMember
2025-06-30
0001611747
us-gaap:RestrictedStockUnitsRSUMember
2025-01-01
2025-06-30
0001611747
us-gaap:RestrictedStockUnitsRSUMember
2026-06-30
0001611747
us-gaap:RestrictedStockUnitsRSUMember
2026-01-01
2026-06-30
0001611747
scni:MarketingGeneralAndAdministrativeExpensesMember
2025-01-01
2025-06-30
0001611747
scni:MarketingGeneralAndAdministrativeExpensesMember
2026-01-01
2026-06-30
0001611747
scni:ResearchAndDevelopmentExpensesMember
2025-01-01
2025-06-30
0001611747
scni:ResearchAndDevelopmentExpensesMember
2026-01-01
2026-06-30
0001611747
scni:CostOfRevenuesMember
2025-01-01
2025-06-30
0001611747
scni:CostOfRevenuesMember
2026-01-01
2026-06-30
0001611747
scni:TwoThousandEighteenIsraeliShareOptionPlanMember
srt:MaximumMember
2026-01-01
2026-06-30
0001611747
scni:TwoThousandEighteenIsraeliShareOptionPlanMember
2026-01-01
2026-06-30
0001611747
scni:TwoThousandFiveIsraeliShareOptionPlanMember
srt:MaximumMember
2026-01-01
2026-06-30
0001611747
scni:TwoThousandFiveIsraeliShareOptionPlanMember
2026-01-01
2026-06-30
0001611747
scni:WarrantInducementAgreementMember
2026-01-01
2026-06-30
0001611747
scni:AmericanDepositarySharesMember
scni:WarrantInducementAgreementMember
2026-06-30
0001611747
scni:WarrantInducementAgreementMember
2026-06-30
0001611747
scni:SeriesBWarrantsMember
2026-04-24
2026-04-24
0001611747
scni:AmericanDepositarySharesMember
scni:SeriesBWarrantsMember
2026-04-24
0001611747
scni:SeriesAWarrantsMember
2026-04-24
2026-04-24
0001611747
scni:AmericanDepositarySharesMember
scni:SeriesAWarrantsMember
2026-04-24
0001611747
scni:AmericanDepositarySharesMember
2026-04-24
0001611747
scni:AmericanDepositarySharesMember
2026-04-24
2026-04-24
0001611747
scni:September2025SEPAMember
2026-06-30
0001611747
scni:September2025SEPAMember
2026-03-02
0001611747
scni:September2025SEPAMember
2026-03-02
2026-03-02
0001611747
scni:YAIIPNLtdMember
2025-09-10
0001611747
scni:AmericanDepositarySharesMember
2025-09-10
2025-09-10
0001611747
2025-09-10
0001611747
scni:AmericanDepositarySharesMember
scni:September2025SEPAMember
2025-09-10
2025-09-10
0001611747
scni:September2025SEPAMember
2025-09-10
2025-09-10
0001611747
scni:AmericanDepositarySharesMember
scni:March2025SEPAMember
2025-01-01
2025-12-31
0001611747
scni:March2025SEPAMember
2025-01-01
2025-12-31
0001611747
scni:March2025SEPAMember
2025-03-03
0001611747
scni:AmericanDepositarySharesMember
scni:March2025SEPAMember
2025-03-03
2025-03-03
0001611747
scni:March2025SEPAMember
2025-03-03
2025-03-03
0001611747
scni:EIBLoanMember
2026-01-01
2026-06-30
0001611747
us-gaap:PreferredStockMember
scni:EIBLoanMember
2024-08-21
2024-08-21
0001611747
scni:EIBLoanMember
2024-08-21
2024-08-21
0001611747
srt:MaximumMember
2026-01-01
2026-06-30
0001611747
srt:MinimumMember
2026-01-01
2026-06-30
0001611747
scni:IsraeliInnovationAuthorityIIAMember
2026-01-01
2026-06-30
0001611747
scni:IsraeliInnovationAuthorityIIAMember
2026-06-30
0001611747
us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember
2026-01-01
2026-06-30
0001611747
scni:SharePurchaseAgreementMember
2026-02-16
0001611747
scni:SharePurchaseAgreementMember
scni:RecipharmIsraelLtdMember
2026-02-16
0001611747
2026-02-16
0001611747
scni:SharePurchaseAgreementMember
scni:RecipharmIsraelLtdMember
2026-02-16
2026-02-16
0001611747
scni:YAMember
2025-09-30
0001611747
scni:YAMember
2026-03-02
0001611747
scni:ADSsMember
scni:YAMember
2026-03-02
2026-03-02
0001611747
scni:RecipharmIsraelLtdMember
2026-01-01
2026-06-30
0001611747
scni:ADSsMember
scni:YAMember
2026-01-01
2026-06-30
0001611747
scni:YAMember
2026-01-01
2026-06-30
0001611747
scni:YAMember
2026-06-30
0001611747
scni:ADSsMember
2026-01-01
2026-06-30
0001611747
scni:ADSsMember
2025-01-01
2025-12-31
0001611747
scni:ADSsMember
2026-03-03
2026-03-03
0001611747
scni:OptionAgreementMember
scni:PinCellsMember
2026-02-27
2026-02-27
0001611747
scni:OptionAgreementMember
2026-02-27
2026-02-27
0001611747
scni:OptionAgreementMember
2025-12-31
0001611747
scni:OptionAgreementMember
2025-01-01
2025-12-31
0001611747
scni:OptionAgreementMember
2026-01-01
2026-06-30
0001611747
2025-03-27
0001611747
2025-03-24
2025-03-24
0001611747
2025-06-30
0001611747
2024-12-31
0001611747
2025-12-31
0001611747
us-gaap:RetainedEarningsMember
2025-06-30
0001611747
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0001611747
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0001611747
us-gaap:PreferredStockMember
2025-06-30
0001611747
us-gaap:CommonStockMember
2025-06-30
0001611747
us-gaap:RetainedEarningsMember
2025-01-01
2025-06-30
0001611747
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-06-30
0001611747
us-gaap:CommonStockMember
2025-01-01
2025-06-30
0001611747
us-gaap:RetainedEarningsMember
2024-12-31
0001611747
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001611747
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001611747
us-gaap:PreferredStockMember
2024-12-31
0001611747
us-gaap:CommonStockMember
2024-12-31
0001611747
us-gaap:RetainedEarningsMember
2026-06-30
0001611747
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-06-30
0001611747
us-gaap:AdditionalPaidInCapitalMember
2026-06-30
0001611747
us-gaap:PreferredStockMember
2026-06-30
0001611747
us-gaap:CommonStockMember
2026-06-30
0001611747
us-gaap:RetainedEarningsMember
2026-01-01
2026-06-30
0001611747
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-06-30
0001611747
us-gaap:CommonStockMember
2026-01-01
2026-06-30
0001611747
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-06-30
0001611747
us-gaap:RetainedEarningsMember
2025-12-31
0001611747
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0001611747
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0001611747
us-gaap:PreferredStockMember
2025-12-31
0001611747
us-gaap:CommonStockMember
2025-12-31
0001611747
us-gaap:PreferredStockMember
2025-01-01
2025-06-30
0001611747
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-06-30
0001611747
us-gaap:PreferredStockMember
2026-01-01
2026-06-30
0001611747
scni:OtherMember
scni:CostOfRevenuesMember
2025-01-01
2025-06-30
0001611747
scni:ContractDevelopmentAndManufacturingOrganizationMember
scni:ExternalMember
2025-01-01
2025-06-30
0001611747
scni:OtherMember
scni:ExternalMember
2025-01-01
2025-06-30
0001611747
scni:ExternalMember
2025-01-01
2025-06-30
0001611747
scni:TwoThousandFiveIsraeliShareOptionPlanMember
srt:MinimumMember
2026-01-01
2026-06-30
0001611747
scni:TwoThousandEighteenIsraeliShareOptionPlanMember
srt:MinimumMember
2026-01-01
2026-06-30
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
xbrli:pure
iso4217:EUR
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant to Rule
13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of August 2026
Commission File Number: 001-37353
SCINAI IMMUNOTHERAPEUTICS LTD.
(Translation of registrant’s name into English)
Jerusalem BioPark, 2nd Floor
Hadassah Ein Kerem Campus
Jerusalem, Israel
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
EXPLANATORY NOTE
Attached are the Company’s press release
providing a business update for the first half of 2026, condensed interim unaudited financial statements and a summary of its operating
and financial review and prospects, each as of June 30, 2026, furnished herewith as Exhibits 99.1, 99.2 and 99.3, respectively
This Report on Form 6-K (including Exhibits 99.1,
99.2 and 99.3) is hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File Nos. 333-291460, 333-271293 and
333-239344) and Form
F-3 (File Nos. 333-295698, 333-274078 and
333-276767), to be
a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed
or furnished.
Exhibit Index
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Scinai Immunotherapeutics Ltd. |
| |
|
|
| Date: August 24, 2026 |
By: |
/s/ Amir Reichman |
| |
|
Amir Reichman |
| |
|
Chief Executive Officer |
